European Journal of Biomedical and Pharmaceutical Sciences

ASSESSMENT OF QUALITY OF LIFE AND CO-MORBIDITIES AMONG CARDIOVASCULAR RISK OBESE PATIENTS AT MULTI SPECIALITY HOSPITAL, BHEEMAVARAM, ANDHRA PRADESH

Gummuluri Jyotsna*, Siram Lakshmi Harika, Dr. K. Prasad, Dr. STK Sridhar and Dr. K. Chandra Sekhar

ABSTRACT

Background: The two most expeditiously growing public health challenging domains across the globe are ‘Obesity’ and ‘Overweight’. It can cause the Coronary heart disease, dyslipidemia, hypertension, stroke, some forms of cancer, type 2 diabetes mellitus, gallbladder disease, osteoarthritis and gout, and pulmonary diseases, including sleep apnoea are the further metabolic consequences resulting from obesity which acts as a major risk factor. In general clinical practice, body mass index (BMI) and to a lesser extent waist circumference (WC) are extensively used measures to assess an individual’s health risk. Objectives: The objective of the current study is to study the Quality of Life of Obesity patients and assess the co-morbidities especially cardiovascular risks based upon the measurement of Waist Circumference and to identify the aetiology of obesity. Materials & Methods: This study was conducted in a multi speciality hospital, among 190 individuals during the period from October 2017 to March 2018. To obtain a reliable and consistent analysis all the information regarding subjects were clearly noted including height, weight, BMI, waist circumference (WC) and hip circumference. Both pharmacological therapy (ORLISTAT) and non-pharmacological therapy includes patient counselling was given to the patients who were enrolled in the study. Multivitamin supplement and protein powder was given to all the patients and in addition ORLISTAT was given to the patients whose BMI is>35. A total 190 patients were studied by using EURO QoL 5D-5L questionnaire. Results: It was observed in the study that females (81.4%) are more physically inactive and are more prone to obese than males. Our findings indicate that 50.52% of women and 44.74% of men falls under high health risk category based on waist circumference and 4.21% of men and less than 1% of women are having moderate health risk. Based on waist to hip ratio 78.95% of patients are having high health risk followed by 9.47% of patients are in moderate risk category and 11.58% of patients are in low risk category. The results of the treatment shows that in morbidity category BMI is reduced by 5.26%, followed by 10% reduction in class-III obesity and 3.16% reduced in overweight category. It was also observed from the study that 7.9% of patients falls into normal BMI after treatment. The scores of these five dimensions were higher before the counselling in all the patients and significant improvement was noticed after counselling in the following domains namely: mobility (mean=1.87), self-care (mean=1.02), usual activities (mean=1.97), pain/discomfort (mean=1.88), anxiety/depression (mean=1.58), index value (mean=83124), visual analogue scale (mean=83.05) during their hospital visit, while the scores were decreased after the counselling. Conclusions: Based on the study results. Obesity was more often in females with less awareness and less physical activity than in males. Decrease in cardiovascular risk was observed in obese patients after pharmacological and non-pharmacological therapy. Most common aetiological factor for obesity was found to be physical inactivity, hereditary and fatty food intake. Most common co-morbidities found along with obesity include Gastritis, Hypertension and Diabetes Mellitus.

Keywords: Age, Sex, Body mass index, Waist Circumference, Co-morbidities, Quality of life.